Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for KSQ Therapeutics

    Client Virtual Booth

    KSQ THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    KSQ Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    610 Main Street North 4th Floor Cambridge MA, 02139
    Telephone
    Telephone
    +617-674-9150
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ksqtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ksq-therapeutics-inc-/
    Twitter
    Twitter
    https://twitter.com/KSQ_TX?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    KSQ Therapeutics and CTMC Announce Strategic Collaboration
    KSQ Therapeutics and CTMC Announce Strategic Collaboration

    https://www.businesswire.com/news/home/20230906816584/en

    BUSINESSWIRE
    06 Sep 2023
    Share Share
    Roche inks KSQ deal to expand stable of synthetic lethal assets
    Roche inks KSQ deal to expand stable of synthetic lethal assets

    https://www.fiercebiotech.com/biotech/roche-finds-usp-cancer-inking-deal-ksq-expand-stable-synthetic-lethal-candidates

    Nick Paul Taylor FIERCE BIOTECH
    13 Jul 2023
    Share Share
    Takeda puts $510M on the line to expand KSQ cancer collaboration
    Takeda puts $510M on the line to expand KSQ cancer collaboration

    https://www.fiercebiotech.com/biotech/takeda-puts-510m-line-expand-ksq-cancer-collaboration

    Nick Paul Taylor FIERCE BIOTECH
    18 May 2023
    Share Share
    Japan's Ono signs up for KSQ's preclinical cancer programs
    Japan's Ono signs up for KSQ's preclinical cancer programs

    https://www.businesswire.com/news/home/20230125005277/en/KSQ-Therapeutics-Announces-Ono-Pharmaceutical-Co.-Ltd.-is-Acquiring-Multiple-Research-Stage-Oncology-Programs-Identified-with-KSQ%E2%80%99s-CRISPRomics%C2%AE-Platform-Technology/?feedref=JjAwJuNHiystnCoBq_hl-R2sso4tCp8l0Yad2mB4_VJcgiwDl5F89IquLVWUqfRVgLxDkSKfgoruKb9yWl5as-PbWreMWuYBefATrZ0EPTVwBy5zzcjujtbJhwuWD3GRBSvR87oUDgbHejiywQBpbg==

    BUSINESSWIRE
    26 Jan 2023
    Share Share
    KSQ Appoints Mahesh Karande to its Board of Directors
    KSQ Appoints Mahesh Karande to its Board of Directors

    https://www.businesswire.com/news/home/20221208005149/en

    BUSINESSWIRE
    08 Dec 2022
    Share Share
    KSQ Announces First Patient Dosed in Combination Portion of PI Study of KSQ-4279
    KSQ Announces First Patient Dosed in Combination Portion of PI Study of KSQ-4279

    https://www.businesswire.com/news/home/20221207005165/en

    BUSINESSWIRE
    07 Dec 2022
    Share Share
    KSQ Therapeutics Announces Leadership and Board Additions
    KSQ Therapeutics Announces Leadership and Board Additions

    https://www.businesswire.com/news/home/20220923005097/en

    BUSINESSWIRE
    23 Sep 2022
    Share Share
    KSQ Tx to Present Data at the AACR 2022 Annual Meeting
    KSQ Tx to Present Data at the AACR 2022 Annual Meeting

    https://www.businesswire.com/news/home/20220322005333/en

    BUSINESSWIRE
    22 Mar 2022
    Share Share
    KSQ Therapeutics Doses First Patient in PI Study of KSQ-4279 in Solid Tumors
    KSQ Therapeutics Doses First Patient in PI Study of KSQ-4279 in Solid Tumors

    https://www.businesswire.com/news/home/20210914005154/en

    BUSINESSWIRE
    14 Sep 2021
    Share Share
    Takeda eyes pathway to natural killer therapies, teeing up $100M to partner KSQ
    Takeda eyes pathway to natural killer therapies, teeing up $100M to partner KSQ

    https://endpts.com/takeda-eyes-pathway-to-natural-killer-therapies-teeing-up-100m-to-partner-with-ksq-for-its-crispr-screened-molecules/

    C. Mitchell ENDPTS
    14 Jan 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search